Combination oncolytic herpes simplex virus and dendritic cell immunotherapy for the treatment of established murine neuroblastomas
Combination oncolytic herpes simplex virus and dendritic cell immunotherapy for the treatment of established murine neuroblastomas. The New England Neurosurgical Society. 2007.